Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HeartFlowHTFL +5.18%12 Net Cash per Share is $1.16 as of Mar. 2026, which is 94% below its 10-year median of 20.97. GuruFocus rates HTFL with a GF Score™ of 12/100. The stock has 3 warning signs investors should review. Among 146 Healthcare Providers & Services companies, HeartFlow ranks worse than 80.14% on this metric.
The historical rank and industry rank for HeartFlow's Net Cash per Share or its related term are showing as below:
HTFL'
s Price-to-Net-Cash Range Over the Past 10 Years
Min: 15.51 Med: 20.97 Max: 22
Current: 21.87
During the past 3 years, the highest Price-to-Net-Cash Ratio of HeartFlow was 22.00. The lowest was 15.51. And the median was 20.97.
HTFL's Price-to-Net-Cash is ranked worse than 80.14% of 146
companies
in the Healthcare Providers & Services industry
Industry Median: 8.16
vs HTFL: 21.87
HeartFlow (NAS:HTFL) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
HeartFlow Net Cash per Share Related Terms
HeartFlow Net Cash per Share Historical Data
* Premium members only.
The historical data trend for HeartFlow's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HTFL vs OMCL, TDOC, OMDA: Net Cash per Share Comparison
For the Health Information Services subindustry, HeartFlow's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HeartFlow Price-to-Net-Cash vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HeartFlow's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where HeartFlow's Price-to-Net-Cash falls into.
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
HeartFlow's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HeartFlow (HTFL) has a Net Cash per Share of $1.16 as of Mar. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on HeartFlow and its competitors. This is 94% below median its historical median of 20.97. Over the past decade, HeartFlow's Net Cash per Share has ranged from 15.51 to 22.00. According to the industry distribution chart, HeartFlow ranks #117 out of 146 companies in the Healthcare Providers & Services industry, placing it in the top 80.1%.
Is HeartFlow's Net Cash per Share too high?
HeartFlow's current Net Cash per Share of $1.16 is 94% below median its 10-year median of 20.97. Over the past 10 years, this metric has ranged from a low of 15.51 to a high of 22.00. The Healthcare Providers & Services industry median Net Cash per Share is 8.16. HeartFlow's value of $1.16 is 85.8% below this industry median. Based on the distribution chart, HeartFlow ranks #117 out of 146 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, HeartFlow has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does HeartFlow's Net Cash per Share compare to OMCL and TDOC?
According to the Healthcare Providers & Services industry distribution chart, HeartFlow ranks #117 out of 146 companies for Net Cash per Share. This places HeartFlow in the lower half of its industry. The industry median Net Cash per Share is 8.16. HeartFlow's value of $1.16 is 85.8% below this benchmark. Historically, HeartFlow's own Net Cash per Share has ranged from 15.51 to 22.00 over the past decade. While the company's 10-year median is 20.97 vs. the industry median of 8.16, HeartFlow has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Healthcare Providers & Services company?
The median Net Cash per Share among Healthcare Providers & Services companies is 8.16, based on 146 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HeartFlow's current Net Cash per Share of $1.16 is 85.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on HeartFlow and its competitors. For the Healthcare Providers & Services industry, the median Net Cash per Share is 8.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HeartFlow's current Net Cash per Share is $1.16, which is 94% below median its own 10-year median of 20.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartFlow stock overvalued right now?
HeartFlow (HTFL) has a current Net Cash per Share of $1.16. The current Net Cash per Share is $1.16, which is 94% below median its 10-year median of 20.97 and 85.8% below the Healthcare Providers & Services industry median of 8.16. HeartFlow's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For HeartFlow (HTFL), the current Net Cash per Share is $1.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
12GF Score
Get the complete analysis for HTFL
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HTFL has been successfully added to your 
